These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 5700392)

  • 1. The effects of oral estrogen-progestin compounds on blood coagulation factors.
    Hodges RM
    Int J Fertil; 1968; 13(4):349-53. PubMed ID: 5700392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Statement on the thromboembolic risk while taking oral contraceptives].
    Rozenbaum H
    Therapeutique; 1970 Apr; 46(4):439-41. PubMed ID: 5427202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestational agents and blood coagulation. VII. Thromboembolic and other complications of oral contraceptive therapy in relationship to pretreatment levels of blood coagulation factors: summary report of a ten-year study.
    Ambrus JL; Mink IB; Courey NG; Niswander K; Moore RH; Ambrus CM; Lillie MA
    Am J Obstet Gynecol; 1976 Aug; 125(8):1057-62. PubMed ID: 133615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboembolic complications of oral contraceptive therapy.
    Ambrus JL; Mink IB; Courey NG; Niswander K; Moore RH; Ambrus CM; Lillie MA
    Res Commun Chem Pathol Pharmacol; 1975 Jan; 10(1):197-200. PubMed ID: 1124318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulatory effects of estrogen.
    Kushner S
    Ohio State Med J; 1970 Oct; 66(10):1016-21. PubMed ID: 4918754
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
    Middeldorp S; Meijers JC; van den Ende AE; van Enk A; Bouma BN; Tans G; Rosing J; Prins MH; Büller HR
    Thromb Haemost; 2000 Jul; 84(1):4-8. PubMed ID: 10928461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal contraception and thromboembolic disease: effects of the oral contraceptives on hemostatic mechanisms. A review of the literature.
    Dugdale M; Masi AT
    J Chronic Dis; 1971 Mar; 23(10):775-90. PubMed ID: 4933752
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
    Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
    Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects and side effects of hormonal contraceptives].
    Carol W; Göretzlehner G
    Z Arztl Fortbild (Jena); 1980 Feb; 74(3):97-104. PubMed ID: 7415248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives, blood clotting and thrombosis.
    Poller L
    Br Med Bull; 1978 May; 34(2):151-6. PubMed ID: 350338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progestational agents and blood coagulation. VI. Relationship of ABO blood types to changes induced by oral contraceptives.
    Lillie MA; Mink IB
    Am J Obstet Gynecol; 1974 Jun; 119(3):406-10. PubMed ID: 4827381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptives and thrombotic disease: risk of venous thromboembolism.
    Helmerhorst FM; Bloemenkamp KW; Rosendaal FR; Vandenbroucke JP
    Thromb Haemost; 1997 Jul; 78(1):327-33. PubMed ID: 9198174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormonal contraception and blood coagulation disorders].
    Schander K; Plotz EJ
    Med Klin; 1974 Feb; 69(7):265-71. PubMed ID: 4596111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombosis and the Pill.
    Vessey MP
    Prescr J; 1970 Feb; 10(1):1-7. PubMed ID: 12254686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Present status of oral contraceptives: 1. effectiveness; basis for selection; side effects; metabolic changes.
    Kistner RW
    Drug Ther (NY); 1971 Dec; 1(12):14-29. PubMed ID: 12306285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hazards of oral contraception using estroprogestational steroids].
    Mauvais-Jarvis P; de Lignieres B; Bercovici JP
    Presse Med (1893); 1969 Oct; 77(41):1419-22. PubMed ID: 5345791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.